Marina Schorpp-Kistner

Title: Marina Schorpp-Kistner: Innovator in Medical Research

Introduction

Marina Schorpp-Kistner is a prominent inventor based in Durmersheim, Germany. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of preeclampsia. With a total of 2 patents, her work has the potential to impact many lives.

Latest Patents

One of her latest patents is focused on the "Use of ADAM 12 for diagnosis and therapy of preeclampsia." This invention highlights the significant role of ADAM 12, ADAM 12-L, and ADAM 12-S in preeclampsia and related disorders. It discusses the use of these genes and gene products, as well as ligands and modulators, in diagnosing and treating preeclampsia and related syndromes. Another notable patent involves "Genetically modified fibroblast cells." This invention describes genetically modified fibroblast cells with specific properties that can aid in identifying compounds that support, inhibit, or modify the AP-1-dependent differentiation and proliferation of keratinocytes.

Career Highlights

Marina has worked with reputable organizations, including the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the German Cancer Research Center Foundation (Deutsche Krebsforschungszentrum Stiftung Des Öffentlichen Rechts). Her work in these institutions has allowed her to advance her research and contribute to significant medical advancements.

Collaborations

Throughout her career, Marina has collaborated with notable colleagues, including Peter Angel and Sabine Gack. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Marina Schorpp-Kistner is a dedicated inventor whose work in medical research is paving the way for innovative solutions in the diagnosis and treatment of preeclampsia. Her contributions are invaluable to the scientific community and hold promise for future advancements in healthcare.